Afrodite Lourbakos

1.7k total citations
18 papers, 873 citations indexed

About

Afrodite Lourbakos is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Afrodite Lourbakos has authored 18 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Oncology. Recurrent topics in Afrodite Lourbakos's work include Muscle Physiology and Disorders (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Afrodite Lourbakos is often cited by papers focused on Muscle Physiology and Disorders (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Afrodite Lourbakos collaborates with scholars based in Australia, United States and Netherlands. Afrodite Lourbakos's co-authors include Robert N. Pike, Jan Potempa, James Travis, Eleanor J. Mackie, Rosemary J. Santulli, Patricia Andrade‐Gordon, Alison L. Jenkins, Carla Chinni, Michael R. D’Andrea and Philip E. Thompson and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

Afrodite Lourbakos

18 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Afrodite Lourbakos Australia 11 321 291 212 159 157 18 873
G. T. Gustafson Sweden 18 96 0.3× 289 1.0× 70 0.3× 56 0.4× 111 0.7× 32 723
T. Bengtsson Sweden 17 81 0.3× 229 0.8× 160 0.8× 48 0.3× 10 0.1× 25 790
Kazuo Sanada Japan 14 45 0.1× 305 1.0× 294 1.4× 132 0.8× 27 0.2× 29 920
Siew‐Ging Gong Canada 16 28 0.1× 403 1.4× 88 0.4× 43 0.3× 29 0.2× 51 724
Luciana O. Almeida Brazil 21 22 0.1× 667 2.3× 89 0.4× 214 1.3× 70 0.4× 47 1.1k
Makram Merimi Belgium 16 33 0.1× 278 1.0× 13 0.1× 150 0.9× 277 1.8× 47 852
Uwe‐Frithjof Haustein Germany 13 31 0.1× 152 0.5× 23 0.1× 43 0.3× 64 0.4× 45 999
K Heije Netherlands 7 49 0.2× 159 0.5× 36 0.2× 43 0.3× 15 0.1× 8 648
Md A. Nahid United States 12 22 0.1× 656 2.3× 74 0.3× 736 4.6× 29 0.2× 13 1.4k
L. Meunier France 15 33 0.1× 210 0.7× 39 0.2× 31 0.2× 27 0.2× 59 1.0k

Countries citing papers authored by Afrodite Lourbakos

Since Specialization
Citations

This map shows the geographic impact of Afrodite Lourbakos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afrodite Lourbakos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afrodite Lourbakos more than expected).

Fields of papers citing papers by Afrodite Lourbakos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afrodite Lourbakos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afrodite Lourbakos. The network helps show where Afrodite Lourbakos may publish in the future.

Co-authorship network of co-authors of Afrodite Lourbakos

This figure shows the co-authorship network connecting the top 25 collaborators of Afrodite Lourbakos. A scholar is included among the top collaborators of Afrodite Lourbakos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afrodite Lourbakos. Afrodite Lourbakos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
McDonald, Craig M., Brenda Wong, Kevin M. Flanigan, et al.. (2018). Placebo‐controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy. Annals of Clinical and Translational Neurology. 5(8). 913–926. 29 indexed citations
2.
3.
Goemans, Nathalie, M. Tulinius, M. van den Hauwe, et al.. (2016). Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study. PLoS ONE. 11(9). e0161955–e0161955. 66 indexed citations
4.
Giannakopoulos, Stavros, et al.. (2015). Identification of Serum Biomarkers for Duchenne Muscular Dystrophy (P2.239). Neurology. 84(14_supplement). 1 indexed citations
5.
Beekman, Chantal, Jessica A. Sipkens, Stavros Giannakopoulos, et al.. (2014). A Sensitive, Reproducible and Objective Immunofluorescence Analysis Method of Dystrophin in Individual Fibers in Samples from Patients with Duchenne Muscular Dystrophy. PLoS ONE. 9(9). e107494–e107494. 33 indexed citations
6.
Ferlini, Alessandra, M. Tulinius, E. Niks, et al.. (2013). T.I.2 Exon skipping and PRO044 in Duchenne muscular dystrophy: Extending the program. Neuromuscular Disorders. 23(9-10). 847–847. 2 indexed citations
7.
Beekman, Chantal, Stavros Giannakopoulos, Jessica A. Sipkens, et al.. (2013). P.13.12 An objective method for immunofluorescence analysis of dystrophin levels in muscle from DMD patients in clinical studies. Neuromuscular Disorders. 23(9-10). 812–812. 2 indexed citations
8.
Lourbakos, Afrodite, Jessica A. Sipkens, Chantal Beekman, et al.. (2011). P1.6 The incidence of revertant and trace dystrophin expression in muscle biopsies of Duchenne Muscular Dystrophy patients with different exon deletions. Neuromuscular Disorders. 21(9-10). 643–643. 6 indexed citations
9.
Foltz, Martin, et al.. (2008). Protein Hydrolysates Induce CCK Release from Enteroendocrine Cells and Act as Partial Agonists of the CCK1Receptor. Journal of Agricultural and Food Chemistry. 56(3). 837–843. 68 indexed citations
10.
Hovenkamp, Egbert, Afrodite Lourbakos, Guus Duchateau, Erwin Tareilus, & Elke A. Trautwein. (2007). Preferential Efflux of Phytosterols over Cholesterol from Macrophages. Lipids. 42(12). 1125–1132. 7 indexed citations
11.
Lomas, David A., et al.. (2002). Hypersensitive mousetraps, alpha1-antitrypsin deficiency and dementia.. PubMed. 30(2). 89–92. 14 indexed citations
12.
Lomas, DA, et al.. (2002). Hypersensitive mousetraps, α1-antitrypsin deficiency and dementia. Biochemical Society Transactions. 30(2). 89–92. 10 indexed citations
13.
Lourbakos, Afrodite, Alison L. Jenkins, James Travis, et al.. (2001). Activation of protease-activated receptors by gingipains fromPorphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood. 97(12). 3790–3797. 188 indexed citations
14.
Lourbakos, Afrodite, Jan Potempa, James Travis, et al.. (2001). Arginine-Specific Protease fromPorphyromonas gingivalisActivates Protease-Activated Receptors on Human Oral Epithelial Cells and Induces Interleukin-6 Secretion. Infection and Immunity. 69(8). 5121–5130. 185 indexed citations
15.
Abraham, Linda, Carla Chinni, Alison L. Jenkins, et al.. (2000). Expression of protease-activated receptor-2 by osteoblasts. Bone. 26(1). 7–14. 54 indexed citations
16.
Smith, Rosealee, Alison L. Jenkins, Afrodite Lourbakos, et al.. (2000). Evidence for the activation of PAR‐2 by the sperm protease, acrosin: expression of the receptor on oocytes. FEBS Letters. 484(3). 285–290. 43 indexed citations
17.
Lourbakos, Afrodite, Carla Chinni, Philip E. Thompson, et al.. (1998). Cleavage and activation of proteinase‐activated receptor‐2 on human neutrophils by gingipain‐R from Porphyromonas gingivalis. FEBS Letters. 435(1). 45–48. 135 indexed citations
18.
Prescott, Mark J., et al.. (1997). A novel fluorescent marker for assembled mitochondria ATP synthase of yeast. FEBS Letters. 411(1). 97–101. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. T. Gustafson Breakdown of academic impact, for papers by T. Bengtsson Breakdown of academic impact, for papers by Kazuo Sanada Breakdown of academic impact, for papers by Siew‐Ging Gong Breakdown of academic impact, for papers by Luciana O. Almeida Breakdown of academic impact, for papers by Makram Merimi Breakdown of academic impact, for papers by Uwe‐Frithjof Haustein Breakdown of academic impact, for papers by K Heije Breakdown of academic impact, for papers by Md A. Nahid Breakdown of academic impact, for papers by L. Meunier
Rankless by CCL
2026